Direct hemoperfusion with a polymyxin B column versus vasopressin for gram negative septic shock: A matched cohort study of the effect on survival

Clinical Nephrology

Volumn 79, Issue 6, 2013, Pages 463-470

  Sawa, Naoki ^a   Ubara, Yoshibumi ^a   Sumida, Keiichi ^a   Hiramatsu, Rikako ^a   Hasegawa, Eiko ^a   Yamanouchi, Masayuki ^a   Hoshino, Junichi ^a   Suwabe, Tatsuya ^a   Uchida, Naoyuki ^a   Wake, Atsushi ^a   Taniguchi, Shuichi ^a   Takaichi, Kenmei ^a  

^a TORANOMON HOSPITAL   (Japan)

Author keywords

Direct hemoperfusion with a polymyxin B column; Septic shock; Survival rate; Vasopressin

Indexed keywords

DOPAMINE; NAFAMSTAT MESILATE; NORADRENALIN; POLYMYXIN B; VASOPRESSIN;

ADULT; ARTICLE; CAUSE OF DEATH; COHORT ANALYSIS; CONTAINER; CONTINUOUS INFUSION; CONTROLLED STUDY; DEVICE THERAPY; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; FEMALE; GASTROINTESTINAL SURGERY; GRAM NEGATIVE SEPSIS; HEMOPERFUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; RISK REDUCTION; SEPTIC SHOCK; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SURVIVAL; SURVIVAL RATE;

AGED; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HEMOPERFUSION; HUMANS; MALE; MIDDLE AGED; POLYMYXIN B; RETROSPECTIVE STUDIES; SHOCK, SEPTIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS; VASOPRESSINS;

EID: 84880731190     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CN107584     Document Type: Article

References (15)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001; 29: 1303-1310. doi:10.1097/00003246-200107000-00002 PubMed
2. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT et al; International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008; 36: 296-327. doi:10.1097/01.CCM.0000298158.12101.41 PubMed
3. Landry DW, Levin HR, Gallant EM, Ashton RC Jr, Seo S, D'alessandro D, Oz MC, Oliver JA. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation. 1997; 95: 1122-1125. doi:10.1161/01.CIR.95.5.1122 PubMed
4. Dünser MW, Mayr AJ, Ulmer H, Knotzer H, Sumann G, Pajk W, Friesenecker B, Hasibeder WR. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation. 2003; 107: 2313-2319. doi:10.1161/01.CIR.0000066692.71008.BB PubMed
5. Sawa N, Ubara Y, Katori H, Hoshino J, Suwabe T, Takemoto F, Uchida N, Masuoka K, Wake A, Taniguchi S, Takaichi K. The long-term survival rate of catecholamine-resistant septic shock in Japanese patients who received vasopressin therapy. Clin Nephrol. 2009; 72: 129-136. PubMed
6. Russell JA, Walley KR, Singer J, Gordon AC, Hébert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ, Ayers D; VASST Investigators. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008; 358: 877-887. doi:10.1056/NEJMoa067373 PubMed
7. Aoki H, Kodama M, Tani T, Hanasawa K. Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber. Am J Surg. 1994; 167: 412-417. doi:10.1016/0002-9610(94)90126-0 PubMed
8. Shoji H. Extracorporeal endotoxin removal for the treatment of sepsis: endotoxin adsorption cartridge (Toraymyxin). Ther Apher Dial. 2003; 7: 108-114. doi:10.1046/j.1526-0968.2003.00005.x PubMed
9. Parrillo JE, Parker MM, Natanson C, Suffredini AF, Danner RL, Cunnion RE, Ognibene FP. Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med. 1990; 113: 227-242. PubMed
10. Marshall JC, Foster D, Vincent JL, Cook DJ, Cohen J, Dellinger RP, Opal S, Abraham E, Brett SJ, Smith T, Mehta S, Derzko A, Romaschin A; MEDIC Study. Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study. J Infect Dis. 2004; 190: 527-534. doi:10.1086/422254 PubMed
11. Baldwin G, Alpert G, Caputo GL, Baskin M, Parsonnet J, Gillis ZA, Thompson C, Siber GR, Fleisher GR. Effect of polymyxin B on experimental shock from meningococcal and Escherichia coli endotoxins. J Infect Dis. 1991; 164: 542-549. doi:10.1093/infdis/164.3.542 PubMed
12. Shimizu T, Hanasawa K, Sato K, Umeki M, Koga N, Naganuma T, Sato S, Shimonishi T, Ikeda T, Matsuno N, Ono S, Saitoh H, Satoh K, Otani Y, Endo Y, Eguchi Y, Tani T; PMX Treatment Study Group. Direct hemoperfusion with polymyxin-Bimmobilized fiber columns improves septic hypotension and reduces inflammatory mediators in septic patients with colorectal perforation. Langenbecks Arch Surg. 2009; 394: 303-311.
13. Cruz DN, Antonelli M, Fumagalli R, Foltran F, Brienza N, Donati A, Malcangi V, Petrini F, Volta G, Bobbio Pallavicini FM, Rottoli F, Giunta F, Ronco C. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA. 2009; 301: 2445-2452. doi:10.1001/jama.2009.856 PubMed
14. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G; SCCM/ESICM/ACCP/ATS/SIS. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003; 31: 1250-1256. doi:10.1097/01. CCM.0000050454.01978.3B PubMed
15. Ikeda T, Ikeda K, Nagura M, Taniuchi H, Matsushita M, Kiuchi S, Kuroki Y, Suzuki K, Matsuno N. Clinical evaluation of PMX-DHP for hypercytokinemia caused by septic multiple organ failure. Ther Apher Dial. 2004; 8: 293-298. doi:10.1111/j.1526-0968.2004.00167.x PubMed